Skip to main content
OpenTrials

Clinical trial condition

Amino Acid Metabolism, Inborn Errors

Explore clinical trials studying Amino Acid Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

396 public trials 66 recruiting studies
Refine in advanced search Browse all conditions

Amino Acid Metabolism, Inborn Errors trial results

Completed

A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir

NCT00000970

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, +32 more
Locations
  • USC CRS Los Angeles, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • Washington U CRS St Louis, Missouri, United States
  • Memorial Sloan-Kettering Cancer Ctr. New York, United States
View Trial Details
Completed

A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients

NCT00000768

Conditions
Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, Blood-Borne Infections, +30 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • Washington U CRS St Louis, Missouri, United States
  • NY Univ. HIV/AIDS CRS New York, United States
View Trial Details
Completed

The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS

NCT00000989

Conditions
Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, Blood-Borne Infections, +30 more
Locations
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Beth Israel Deaconess - East Campus A0102 CRS Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Ctr. New York, United States
  • Unc Aids Crs Chapel Hill, North Carolina, United States
View Trial Details
Completed

A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes

NCT00001062

Conditions
Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, Blood-Borne Infections, +30 more
Locations
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Rush Univ. Med. Ctr. ACTG CRS Chicago, Illinois, United States
  • Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States
  • Cornell University A2201 New York, United States
View Trial Details
Completed

The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV

NCT00001034

Conditions
Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, Blood-Borne Infections, +32 more
Locations
  • Community Consortium of San Francisco San Francisco, California, United States
  • Denver CPCRA / Denver Public Hlth Denver, Colorado, United States
  • Wilmington Hosp / Med Ctr of Delaware Wilmington, Delaware, United States
  • Veterans Administration Med Ctr / Regional AIDS Program Washington D.C., District of Columbia, United States
View all 17 locations
View Trial Details
Completed

A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease

NCT00000805

Conditions
Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, Blood-Borne Infections, +24 more
Locations
  • Childrens Hosp. LA - Dept. of Ped., Div. of Clinical Immunology & Allergy Los Angeles, California, United States
  • Usc La Nichd Crs Los Angeles, California, United States
  • UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles, California, United States
  • Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab. Oakland, California, United States
View all 19 locations
View Trial Details
Completed

A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure

NCT00000691

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Amino Acid Metabolism, Inborn Errors, +32 more
Locations
  • USC CRS Los Angeles, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • Univ. of Miami AIDS CRS Miami, Florida, United States
  • Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States
View Trial Details

Related conditions